Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
0301 basic medicine
Intestinal Secretions
Biological Availability
Water
Membranes, Artificial
Octreotide
Bile Acids and Salts
Solutions
03 medical and health sciences
0302 clinical medicine
Intestinal Absorption
Solubility
Pancreatin
Deamino Arginine Vasopressin
Colloids
Intestinal Mucosa
Cellulose
Micelles
Phospholipids
Half-Life
DOI:
10.1021/acs.molpharmaceut.1c00309
Publication Date:
2021-07-13T18:35:28Z
AUTHORS (3)
ABSTRACT
Peptide drugs face several barriers to oral delivery, including enzymatic degradation in the gastrointestinal tract and low membrane permeability. Importantly, direct interaction between various biorelevant colloids (i.e., bile salt micelles salt-phospholipid mixed micelles) present aqueous environment peptide drug molecules has not been studied. In this work, we systematically characterized interactions a water-soluble model drug, octreotide, range of physiologically relevant salts solution. Octreotide flux pure solutions commercially available media, i.e., fasted state simulated intestinal fluid (FaSSIF) fed (FeSSIF), was evaluated using side-by-side diffusion cell equipped with cellulose dialysis membrane. All seven micellar as well FaSSIF FeSSIF decreased octreotide flux, dihydroxy were found have much larger effect than trihydroxy salts. An inverse relationship pancreatic stability also observed; provided protective toward prolonged half-life vitro. Diffusion ordered nuclear magnetic resonance (DOSY NMR) spectroscopy dynamic light scattering (DLS) used complementary experimental techniques confirm peptide-micelle Experiments performed desmopressin second drug; interacted solution, albeit lower extent relative octreotide. The findings described herein demonstrate that amphiphilic, do interact phospholipids an on stability. Correspondingly, absorption bioavailability may be impacted.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (62)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....